An underground market for unapproved slimming drugs is propelled by social media fitness personalities and vendors on communication apps, based on recent findings.
Experimental Drug Gaining Traction Online
The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are urged to message these profiles directly for supplier links, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Separately, a robust trade exists on messaging services, where groups with numerous of members share comparison photos, administration instructions and claims of next-day UK delivery. Sellers market the substance there before directing buyers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Experts Voice Concerns
Nevertheless, doctors and chemists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to users administering substances of uncertain source.
Several professionals stated the demand for retatrutide could be linked to the increasing price of approved slimming products such as Mounjaro.
Legal Position and Implementation
Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach medicines, advertising, and customer laws, risking fines, prosecution or prison.
Platform Reaction and Material Removal
According to TikTok, the platform has removed problematic material and prohibited related hashtags and search suggestions. The organization stated it was dedicated to maintaining the platform safe and allocating resources in enhancing enforcement strategies.
Digital Trading Operations
Investigations also discovered groups with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, filled with photos of slimming results, glowing reviews and step-by-step instructions for mixing or administering at home.
Within moments of entering one community, a vendor posted WhatsApp details, where most transactions take place. The vendor provided an instruction manual and guaranteed shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.
Item Information and Costs
Within these groups, posts show dark colored parcels with postal service stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20mg. When questioned how long a injector should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for the messaging service said it regularly monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are administering materials they cannot confirm. Although the science behind this drug is sound, these digital products may not include what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.
Her team has already encountered patients injured by self-injection from unverified suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may subject users to possibly serious medical dangers”.
